TRAVERE THERAPEUTICS, INC. Acquisitions, Net of Cash Acquired
TRAVERE THERAPEUTICS, INC. (TVTX) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2023-02-23
- TRAVERE THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2017-09-30 was $0.00.
- TRAVERE THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2016-12-31 was $115.00K.
- TRAVERE THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2016-09-30 was $0.00.
- TRAVERE THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00.
- TRAVERE THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- TRAVERE THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2020 was $95.28M.
- TRAVERE THERAPEUTICS, INC. payments to acquire businesses, net of cash acquired for fiscal 2019 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-23 | |||||
| 2021-12-31 | $0.00 10-K · filed 2023-02-23 | |||||
| 2020-12-31 | $95.28M 10-K · filed 2023-02-23 | |||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 | |||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | ||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | |||||
| 2016-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $115.00K derived: sum of 2 quarters · filed 2019-02-26 | $615.00K derived: sum of 3 quarters · filed 2019-02-26 | $615.00K 10-K · filed 2019-02-26 | $500.00K 10-K · filed 2017-03-01 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $500.00K derived: sum of 2 quarters · filed 2017-11-07 | $500.00K 10-Q · filed 2017-11-07 | $500.00K derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2016-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $500.00K 10-Q · filed 2017-08-09 | $500.00K derived: sum of 3 quarters · filed 2018-07-06 | $500.00K derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2018-07-06 | $0.00 derived: sum of 3 quarters · filed 2018-07-06 | $0.00 derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | $0.00 derived: sum of 2 quarters · filed 2018-07-06 | $0.00 derived: sum of 3 quarters · filed 2018-07-06 | $33.43M 10-K · filed 2018-07-06 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | $33.43M 10-Q · filed 2016-11-04 | $33.43M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $33.43M 10-Q · filed 2016-08-05 | $33.43M derived: sum of 3 quarters · filed 2017-03-01 | $33.43M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $33.43M 10-Q · filed 2016-05-05 | $33.43M 10-Q · filed 2015-05-11 | $33.43M derived: sum of 2 quarters · filed 2017-03-01 | $33.43M derived: sum of 3 quarters · filed 2017-03-01 | $33.43M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | $29.15M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $29.15M 10-Q · filed 2015-11-06 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $29.15M 10-Q · filed 2015-08-10 | ||||
| 2014-03-31 | $29.15M 10-Q · filed 2015-05-11 | |||||
| 2013-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |